US Secretary of Health and Human Services Robert F. Kennedy Jr. released a new policy on Wednesday announcing that six unofficially approved peptides will be temporarily allowed to be sold on the market. Despite repeated warnings from scientists within the government, stating that there is currently insufficient evidence to confirm the safety and efficacy of these peptides, the policy is still being implemented. According to this latest policy, the Ministry of Health will no longer prevent dispensing pharmacies from supplying these widely used peptides. As the US Food and Drug Administration is currently evaluating whether to officially allow the formulation of these ingredients, the entire approval process is expected to take months or more. Outside analysts believe JFK's move may weaken the FDA's regulatory powers to restrict such peptides in the future. Also, according to two people familiar with the matter, in response to JFK's decision to lift peptide restrictions, a large number of staff within the FDA have clearly indicated that they do not support it.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.